Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury. 2023

Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.

Spinal cord injury (SCI) often causes loss of sensory and motor function resulting in a significant reduction in quality of life for patients. Currently, no therapies are available that can repair spinal cord tissue. After the primary SCI, an acute inflammatory response induces further tissue damage in a process known as secondary injury. Targeting secondary injury to prevent additional tissue damage during the acute and subacute phases of SCI represents a promising strategy to improve patient outcomes. Here, we review clinical trials of neuroprotective therapeutics expected to mitigate secondary injury, focusing primarily on those in the last decade. The strategies discussed are broadly categorized as acute-phase procedural/surgical interventions, systemically delivered pharmacological agents, and cell-based therapies. In addition, we summarize the potential for combinatorial therapies and considerations.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords
D013119 Spinal Cord Injuries Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.). Myelopathy, Traumatic,Injuries, Spinal Cord,Post-Traumatic Myelopathy,Spinal Cord Contusion,Spinal Cord Laceration,Spinal Cord Transection,Spinal Cord Trauma,Contusion, Spinal Cord,Contusions, Spinal Cord,Cord Contusion, Spinal,Cord Contusions, Spinal,Cord Injuries, Spinal,Cord Injury, Spinal,Cord Laceration, Spinal,Cord Lacerations, Spinal,Cord Transection, Spinal,Cord Transections, Spinal,Cord Trauma, Spinal,Cord Traumas, Spinal,Injury, Spinal Cord,Laceration, Spinal Cord,Lacerations, Spinal Cord,Myelopathies, Post-Traumatic,Myelopathies, Traumatic,Myelopathy, Post-Traumatic,Post Traumatic Myelopathy,Post-Traumatic Myelopathies,Spinal Cord Contusions,Spinal Cord Injury,Spinal Cord Lacerations,Spinal Cord Transections,Spinal Cord Traumas,Transection, Spinal Cord,Transections, Spinal Cord,Trauma, Spinal Cord,Traumas, Spinal Cord,Traumatic Myelopathies,Traumatic Myelopathy
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective

Related Publications

Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
July 2018, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
September 2022, Neural regeneration research,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
November 2020, Journal of neuroinflammation,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
October 2009, European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
May 2008, Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
March 2005, Proceedings of the National Academy of Sciences of the United States of America,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
December 2021, The aging male : the official journal of the International Society for the Study of the Aging Male,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
October 2017, Neurochemical research,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
June 2008, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Zin Z Khaing, and Jessica Y Chen, and Gevick Safarians, and Sohib Ezubeik, and Nicolas Pedroncelli, and Rebecca D Duquette, and Tobias Prasse, and Stephanie K Seidlits
April 2021, Journal of neuroinflammation,
Copied contents to your clipboard!